Business Context and Reporting Period
Company: Helen of Troy Limited
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended May 31, 2003 (First Quarter of Fiscal 2004)
Business Overview: The company manufactures and markets personal care appliances, hair and skin care products, and other consumer goods. Operations are divided into North American, International, and Tactica segments. A significant recent development was the October 2002 acquisition of the Idelle Labs division (six brand names) from Procter & Gamble.
Key Financial Metrics
| Metric (in thousands) | Q1 2004 (Ended May 31, 2003) | Q1 2003 (Ended May 31, 2002) |
|---|---|---|
| Net Sales | $106,500 | $102,483 |
| Gross Profit | $52,795 | $49,515 |
| Gross Margin | 49.6% | 48.3% |
| Operating Income | $16,196 | $10,011 |
| Net Earnings | $14,844 | $6,591 |
| Diluted EPS | $0.50 | $0.22 |
| Cash & Equivalents (End of Period) | $32,606 | $88,410 |
| Long-Term Debt | $55,000 | $55,000 |
| Working Capital | $188,889 | $173,809 |
Cash Flow Summary: Operating activities used $13.5 million in cash (compared to providing $25.6 million in the prior year), primarily due to increased inventory and accounts receivable. Investing activities used $1.9 million, and financing activities provided $0.1 million.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4% ($4.0 million) year-over-year. The North American segment grew 13% (driven 85% by the new Idelle Labs division), and the International segment surged 134%. Conversely, the Tactica segment declined 42% due to decreased sales of Epil-Stop products.
- Profitability: Net earnings more than doubled to $14.8 million from $6.6 million. Operating income rose 62% to $16.2 million.
- Unusual Items: "Other income, net" included a $2.6 million gain from the settlement of two litigation matters (Schawbel Corporation and another lawsuit), significantly boosting net income.
- Expense Management: SG&A expenses as a percentage of sales decreased from 38.5% to 34.4%, aided by lower advertising costs in the Tactica segment and foreign currency exchange gains of $566,000.
- Liquidity: Cash balances decreased 31.8% quarter-over-quarter due to working capital buildup for anticipated sales and the new product line.
Guidance, Outlook, Risks, and Contingencies
Outlook & Capital Resources: Management believes cash flows and financing sources are sufficient for foreseeable needs. Capital needs will focus on inventory and receivables. The company maintains a $25 million revolving credit line (currently unutilized) expiring August 31, 2003, which is expected to be renewed or replaced.
Stock Repurchase: The Board authorized the repurchase of up to 3,000,000 shares through May 31, 2006; no shares have been repurchased to date.
Material Risks & Contingencies:
- Tax Disputes:
- Hong Kong: The Inland Revenue Department (IRD) assessed $6.75 million in taxes for 1995-1997. If applied to later years, the liability could reach ~$37 million. The company has recorded a liability and holds $3.28 million in tax reserve certificates.
- U.S. IRS: The IRS is auditing returns for 1997-1999 with proposed adjustments that could result in a $7.5 million liability. The company plans to contest these vigorously.
- Legislative Risk: Proposed U.S. tax legislation could eliminate current tax benefits derived from the company's international corporate structure, potentially materially increasing the effective tax rate.
- Foreign Currency: The company hedges portions of British Pound and Euro exposure but remains subject to exchange rate fluctuations on unhedged sales.
Investor Verification Checklist
- Tax Liability Exposure: Verify the status of the Hong Kong IRD assessment and the U.S. IRS audit, as potential liabilities ($37M and $7.5M respectively) are significant relative to net earnings.
- Idelle Labs Integration: Confirm that sales growth from the Procter & Gamble acquisition is sustainable and not merely a one-time step-change.
- Tactica Segment Turnaround: Assess the strategy to reverse the 42% sales decline in the Tactica segment and the timeline for eliminating its accumulated deficit.
- Working Capital Efficiency: Monitor the trend of inventory and receivables, which consumed significant cash in this quarter.
- Debt Covenants: Ensure continued compliance with the revolving credit agreement covenants (debt-to-EBITDA, fixed charge coverage) as the line expires in August 2003.